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The role of HLA-DR genetic make-up on the IgG, IgA  
and IgM antibody response to Mycobacterium tubercu-
losis culture filtrate and 30 kDa antigens was studied 
in pulmonary tuberculosis. The study was carried out 
in HLA-DR typed active pulmonary tuberculosis 
(ATB) patients (n = 37), inactive (cured) pulmonary 
tuberculosis (ITB) patients (n = 79) and normal healthy 
subjects (NHS; n = 46). In ATB and ITB (cured) pa-
tients, IgG antibody (optical density at 490 nm for 
1 : 3200 dilution) as measured by enzyme-linked im-
munosorbent assay was the predominant one than IgA 
and IgM antibodies. Increased IgG antibody titre to 
culture filtrate (P = 0.03) and decreased titre to 30kDa 
antigen were observed with HLA-DR1-positive ATB 
patients than non-DR1 (ATB) patients. Moreover, 
HLA -DR4- and HLA-DR6-positive ATB patients 
showed trends toward an increased IgG antibody res-
ponse to 30 kDa antigen than HLA-DR4- and HLA-
DR6-negative (ATB) patients respectively. Signifi-
cantly increased IgA antibody to 30 kDa antigen was 
observed with HLA-DR1-positive ATB patients than 
non-DR1 patients (P = 0.03). The study suggests that 
multiple HLA-DR molecules may regulate the IgG and 
IgA antibody responses to various proteins of M. tu-
berculosis. Moreover, HLA-DR phenotypes and in-
creased IgG and IgA antibody titres may be useful to 
differentiate M. tuberculosis- nfected subjects from 
normal subjects and cured patients with the same 
HLA -DR phenotypes or genetic make-up. 
 
MYCOBACTERIAL infections are associated with the pro-
duction of circulating antibodies and development of cell- 
mediated immune functions. Although antibody titres tend 
to be higher in tuberculosis patients than normal subjects,  
results have been disappointing for serodiagnosis of tu-
berculosis because of verlapping antibody response.  
Protein antigens of mycobacteria are characterized by  
cross-reactivity when analysed for antibodies otain d by  
experimental immunization or by those arising during  
natural mycobacterial infection. Species specificity is rare  
at the level of individual proteins, as would be expected  
f major proteins of functional significance1,2. Identifica-
tion of antigens and their antigenic determinants is im-
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portant for an understanding of the interactions involed 
in the immune response to Mycobacterium tuberculosis 
and may be of potential value in the design of diagnostic
reagents and subunit vaccines. In this context, the grow-
ing number of defined and available mycobacterial anti-
gens now provide a rational basis for subunit vacci e 
design and development of specific diagnostic reagents3. 
Of the many M. tuberculosis antigens, antigen 85 com-
plex (30–31 kDa), 65 kDa antigen, 38kDa antigen, 16 kDa 
antigen and ESAT-6 are some which are well character-
ized for serodiagnosis as well as for subunit vaccine. 
Subunit vaccine approach has to rely on identification and 
application of protein antigens recognized by protective 
T-cells within HLA heterogenous population4. Recently, 
it has been shown that the memory T-cell responses to 
85 kDa antigen complex, peptides of ESAT-6 and 65 kDa 
heat-shock protein are subject to effective host genetic 
regulation5. HLA restriction of CD8 + T-cell epitope of 
85 complex of M. tuberculosis6,7 and naturally derived 
Th1 cell epitopes of 85B (30 kDa) antigen of M. tubercu-
losis has been studied8. Earlier studies carried out in HLA 
and tuberculosis revealed an increased antibody response 
to 38 kDa antigen in patients with HLA-DR2 phenotype9. 
Further, it has been shown that HLA-DR15, a split of 
HLA-DR2 is associated with high levels of antibodies to 
38 kDa antigen10. The influence of HLA-DR on humoral 
and lymphocyte response in pulmonary tuberculosis has 
also been studied by us earlier11,12. The present s udy was 
attempted to understand the regulatory role of polymor-
phic HLA-DR molecules on the IgG, IgA and IgM anti-
body responses to M. tuberculosis antigens, as well as to 
find out whether HLA-DR genetic make-up of the indi-
viduals is useful to differentiate M. uberculosis-infected 
subjects (active TB patients) from the end mic normal 
subjects and cured patients by detecting IgG, IgA and IgM 
antibodies to culture filtrate antigen (CFA) and 30 kDa 
antigen. 
 Subjects included were 37 active pulmonary tuberculo-
sis (ATB) patients, 79 inactive tuberculosis (ITB) patients 
(cured) and 46 normal healthy subject  (NHS). The mean 
age with standard error was 38.5 ± 1.9; 40.2 ± 1.2 and 
37.3 ± 1.3 yr respectively. ATB patients attending Tuber-
culosis Research Centre, Chennai with respiratory symp-
toms and radiographic abnormalities suggestive of pul-
monary TB were studied. They were sputum-posi ive for 
M. tuberculosis by smear and culture. These patients were 
considered as the infected group. Blood samples were 
collected before the start of chemotherapy. ITB (cured 
patients) were selected from among subjects of an earlier 
chemotherapy study. Patients classified as suffering from 
ATB had received supervized short-course chemotherapy 
of 6–8 months duration and had been followed up for five 
years after treatment. At the time of blood-sample collec-
tion, all these cured patients were in the quiescent stage 
of the disease. NHS (n = 46) consisted of laboratory vol-
unteers (n = 32) of our centre working for more than 
three years and the patient contacts (n = 14) (spouses of 
the patients) who were living to ether with the patients 
before, during and after treatment. The pa ients and NHS 
b longed to the same ethnic origin.
 Twenty millilitres of peripheral blood was drawn in 
heparin (20 units/ml) from patients and NHS. The mono-
nuclear cells were separated using ficoll hypaque density 
gradient centrifugation as described by Boyum13. Plasma 
was aspirated and stored at –20°C until use. T- and B-
lymphocytes were separated from peripheral blood mono-
nuclear cells using nylon wool column and adherent cell 
population (enriched B-lymphocytes) was used for HLA-
DR typing using two-stage microlymphocytotoxici y as-
say14. Commercial sources of antisera (Biotest, Frankfurt, 
Germany) were used for HLA-DR typing and at least 
three antisera were used for each specificity studied15. 
 CFA and 30 kDa antigen were prepared as described 
earlier16,17. Briefly, M. tuberculosis H37Rv was grown in 
Sauton’s liquid medium for 6 weeks as a surface pellicle. 
Bacilli were removed by centrifugation and the culture 
supernatant was filtered through Seitz filter. The proteins 
in th  culture filtrate were precipitated with 90% ammo-
nium sulphate saturation. The final precipitate was dissol-
ved and dialysed against PBS (0.1 M, pH 7.2) extensively. 
The antigen was aliquoted and stored at –70°C in the 
presence of sodium azide and the protease inhibitor phe-
nylmethyl sulfonyl fluoride16. 
 Two-step purification was carried out for the separa-
tion of 30 kDa antigen (85B) from CFA17. The first-step 
purification included anion exchange chromatography 
(QAE-Sepharose). Tris-HCl 0.05 M, pH 8.1-buffer was 
used as the starting buffer and a linear gradient of 0–
100% 0.05 Tris-HCl, pH 8.1 with 1.0 M sodium chloride 
was used for elution. The run was carried in the High Per-
formance Liquid Chromotography system (Millennium 
V2.00, Waters, USA). The Ag85 complex containing 
fractions were pooled. Second-step purification of antigen 
A, B and C components from the Ag85 complex was 
done by passing it through the hydrophobic interaction 
chromatography column, namely the phenyl sepharose 
HP column using three different buffers: buffer A consi-
sting of 0.01 M NaH2PO4, pH 6.8 for washing; buffer B, 
0.01 M Tris-glycine pH 8.0 for binding and buffer C, 
0.01 M Tris-glycine with 50% ethylene glycol, pH 8.9 for 
elution. The fraction containing antigen 85 B alone was 
used to sensitize ELISA plates at a concentration of 1 mg/ 
ml. 
 IgG, IgA and IgM antibody levels against CFA and 
30 kDa antigen of M. tuberculosis H37Rv were estimated 
in the plasma of HLA-DR typed ATB patients, ITB (cured) 
patients and NHS.  
 ELISA plates (Nunc Maxisorp Certified, flat-bottomed) 
were coated with an optimal concentration of purified an-
tigens of M. tuberculosis in 0.06 M carbonate buffer, pH 
9.6 and incubated overnight at 4°C. The plates were 
washed four times with PBS containing 0.1% Tween 20 
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(PBST) using the automatic ELISA washer (Organon Tek-
nika, Austria). The non-specific sites in the wells were 
blocked with 1% bovine serum albumin (BSA) for 1 h at 
37°C. After four washes with PBST, the plates were incu-
bated with sera from patients and normals (1 : 3200 dilu-
tion). The 1 : 3200 dilution was selected based on the 
previous experiments. The plates were washed after 1  in-
cubation at 37°C and further incubated with anti-human 
IgG, IgA or IgM peroxidase conjugate (Jackson, USA) in 
PBST containing 1% BSA. After 1 h of incubation at 
37°C, the plates were washed and colour developed by the 
addition of 100 ml of substrate (50 ml of phosphate–citrate 
buffer, containing 20 mg of ortho-phenylenediamine and 
30 ml of hydrogen peroxide) to each well. The reaction was 
arrested by adding 50 ml of 8N H2SO4. The plates were 
read using Spectramax ELISA reader (Molecular Devices, 
USA) at 490 nm wavelength. Pooled TB plasma and PBST 
buffer were used as the positive and negative controls r-
sp ctively, in each plate. The mean absorbance and sta -
dard error (SE) of the normal were calculated.  
 The frequencies of HLA-DR antigens in patients and 
controls were determined by direct count. The results on 
antibody titre (OD490 at 1
 : 3200 dilution) are expr ssed as 
mean ± SE. Student’s t test was applied to see the signifi-
cance of the data. P values less than 0.05 are considered 
as significant. 
 The antibody response to M. tuberculosis CFA and 
30kDa antigen as measured by the optical density 
(OD490) at 1 in 3200 dilution, was higher in ATB patients 
than ITB (cured) patients and NHS. The IgG antibody re-
sponse to CFA and 30kDa antigen was higher in ATB 
patients compared to cured patients and NHS. Moreover, 
IgG antibody titre was higher than IgA and IgM antibod-
ies (data not shown).  
 
 
 
 
 
Figure 1. HLA-DR phenotypes and IgG antibody response (optical density at 490 nm) to M. tuberculo-
sis culture filtrate and 30 kDa antigen in normal healthy subjects (NHS), active pulmonary tuberculosis 
(ATB) and inactive pulmonary tuberculosis (ITB) patients. The results are expressed as arithmetic 
mean ± standard error 
 
 NHS ATB ITB  NHS ATB ITB 
 (n)  (n) (n)   (n)  (n)  (n) 
HLA-DR1-positive  10 4 12 Non-DR1 36 33 67 
HLA-DR2-positive  18 17 38 Non-DR2 28 20 41 
HLA-DR3-positive  4 9 12 Non-DR3 42 28 67 
HLA-DR4-positive  11 7 23 Non-DR4 35 30 56 
HLA-DR5-positive  11 5 15 Non-DR5 35 32 64 
HLA-DR6-positive  10 12 10 Non-DR6 36 25 69 
HLA-DR7-positive  22 12 28 Non-DR7 24 25 51 
HLA-DR8-positive  3 3 8 Non-DR8 43 34 71 
HLA-DR9-positive  ND 4 6 Non-DR9 ND ND 73 
HLA-DR10-positive  ND ND 6 Non-DR10 ND 33 73 
 
ATB: HLA-DR1-positive vs HLA-DR1-negative: IgG antibody to CFA P = 0.03; n, Number of individu-
als studied in each group, ND, Not determin d. 
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Table 1. IgA antibody titre (optical density at 490 nm) to CFA and 30kDa antigen in selected HLA-DR phenotypes of NHS, ATB and ITB patients 
 CFA 30 kDa antigen 
HLA-DR 
phenotype NHS ATB ITB NHS ATB ITB 
 
DR1-positive 0.199 ± 0.062 (10) 0.599 ± 0.185 (4) 0.276 ± 0.044 (12) 0.173 ± 0.033 (10) 1.018* ± 0.179 (4) 0.390 ± 0.045 (12) 
DR1-negative 0.232 ± 0.030 (36) 0.344 ± 0.045 (33) 0.333 ± 0.026 (67) 0.269 ± 0.038 (36) 0.373* ± 0.040 (33) 0.405 ± 0.038 (67) 
 
DR4-positive 0.293 ± 0.079 (11) 0.414 ± 0.074 (7) 0.297 ± 0.040 (23) 0.300 ± 0.041 (11) 0.408 ± 0.093 (7) 0.332 ± 0.047 (23) 
DR4-negative 0.202 ± 0.023 (35) 0.362 ± 0.054 (30) 0.336 ± 0.028 (56) 0.231 ± 0.039 (35) 0.450 ± 0.061 (30) 0.432 ± 0.042 (56) 
 
DR6-positive 0.240 ± 0.038 (10) 0.312 ± 0.072 (12) 0.290 ± 0.03  (10) 0.373 ± 0.104 (10) 0.336 ± 0.075 (12) 0.513 ± 0.128 (10) 
DR6-negative 0.220 ± 0.033 (36) 0.396 ± 0.058 (25) 0.312 ± 0.025 (69) 0.213 ± 0.026 (36) 0.494 ± 0.066 (25) 0.387 ± 0.033 (69) 
Numbers in parentheses represent the individuals studied in each group. *P = 0.03. 
 
 
Table 2. IgM antibody titre (optical density at 490 nm) to CFA and 30 kDa antigen in selected HLA-DR phenotypes of NHS,  
  ATB and ITB patients 
 CFA 30 kDa antigen 
HLA-DR 
phenotype NHS ATB ITB NHS ATB ITB 
 
DR1-positive 0.114 ± 0.045 0.734 ± 0.315 0.424 ± 0.126 0.264 ± 0.048 0.537 ± 0.172 0.402 ± 0.064 
DR1-negative 0.232 ± 0.031 0.250 ± 0.054 0.290 ± 0.029 0.402 ± 0.043 0.342 ± 0.045 0.340 ± 0.021 
 
DR4-positive 0.206 ± 0.033 0.150 ± 0.045 0.351 ± 0.077 0.401 ± 0.077 0.231 ± 0.069 0.366 ± 0.034 
DR4-negative 0.206 ± 0.034 0.338 ± 0.075 0.294 ± 0.031 0.363 ± 0.041 0.394 ± 0.051 0.338 ± 0.024 
 
DR6-positive 0.285 ± 0.080 0.239 ± 0.065 0.272 ± 0.044 0.448 ± 0.087 0.396 ± 0.095 0.352 ± 0.055 
DR6-negative 0.184 ± 0.026 0.332 ± 0.087 0.316 ± 0.035 0.351 ± 0.039 0.347 ± 0.048 0.349 ± 0.022 
Number of individuals studied in each group is similar to that in Table 1. 
 
 
 An increased IgG antibody response to CFA was obser-
ved in HLA-DR1-positive ATB patients than HLA-DR1-
negative ATB patients (P = 0.03), whereas a trend towards 
a decreased IgG antibody titre to 30 kDa antigen was ob-
served in HLA-DR1-positive ATB patients than HLA-
DR1-negative ATB patients. Such a difference was not 
observed in NHS or cured patients to CFA and 30 kDa an-
tigen (Figure 1). Among the ATB patients, HLA-DR4- 
and HLA-DR6-positive patients showed trends toward an 
increased IgG antibody response to 30 kDa antigen when 
compared to HLA-DR4- and HLA-DR6-negative patients 
respectively. 
 HLA-DR1-positive ATB patients showed a significantly 
increased IgA antibody response to 30 kDa antigen than 
DR1-negative (non-DR1) ATB patients (P = 0.03). Simi-
lar trend was also observed with CFA. No marked change 
in the IgA antibody titre was observed in HLA-DR4- and 
HLA-DR6-positive ATB patients compared to HLA-DR4- 
and HLA-DR6-negative patients (Table 1). The IgM anti-
body responses to various M. tuberculosis antigens studied 
were not influenced by HLA-DR phenotypes (Table 2). 
 In the present study, higher IgG antibody response to 
CFA and 30 kDa antigen of M. tuberculosis was observed 
in ATB patients than ITB (cured) patients and NHS. This 
suggests that IgG antibody is the predominant antibody 
which may be produced during the active stage of the 
disease and may persist for a longer time even after cure. 
It has been suggested that the antibody levels are more 
closely related to the disease activity and anti-TB treat-
ment18,19. Moreover, the IgG, IgA and IgM antibody res-
ponses of cured patients (cured ten years back) were 
comparable to those of NHS, which reflects a picture 
similar to that of NHS.  
 HLA-DR1-positive ATB patients exhibited a signifi-
cantly higher IgG antibody titre to CFA and IgA antibody 
titre to 30 kDa antigen than HLA-DR1-negative ATB pa-
tients. This suggests that HLA-DR1 may probably aug-
ment IgG and IgA antibody responses to M. tuberculosis 
antigens during the active stage of tuberculosis, probably 
through a shift from Th1 (associated with protective im-
munity) to Th2 type (associated with humoral immunity) 
of response. More ver, HLA-DR4- and HLA-DR6-posi-
tive ATB patients showed a trend towards a higher IgG 
antibody titre to 30 kDa antigen than HLA-DR4-negative 
and HLA-DR6-negative ATB patients. This suggests that 
multiple major histocompatibility complex molecules 
may regulate the humoral immune responses to the pro-
teins of M. tuberculosis antigens during the active stage 
of t e disease. Multiple HLA-DR molecules have been 
shown to be associated in inducing protective Th1 res-
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ponse to 18, 28 and 65 kDa proteins of M. tuberculosis20. 
This may be due to the recognition of different epitopes 
of the M. tuberculosis antigens by different HLA-DR 
molecules in association with T-cell receptor. Further, the 
present study suggests that HLA-DR1, HLA-DR4 and 
HLA-DR6 phenotypes may be useful to differentiate M. 
tuberculosis-infected subjects from NHS and cured patie-
nts with HLA-DR1, HLA-DR4 and HLA-DR6 phenotypes 
based on the high IgG and IgA antibodies to M. tubercu-
losis CFA and 30 kDa antigen. Moreover, IgG and IgA 
antibody responses to a battery of M. tuberculosis anti-
gens may throw more light on HLA-DR phenotype-based 
differentiation of M. tuberculosis-infected individuals from 
NHS and cured patients in a genetically heterogenous 
population.  
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The haemoglobinopathies – thalassaemias and abnor-
mal haemoglobins – constitute a major burden of genetic 
diseases in India. Our study, based on index cases 
from 120 families detected between May 1999 and May 
2003, highlights the ethnic distribution of haemoglo-
binopathies in regions in and around Varanasi com-
prising 8–10 districts of eastern Uttar Pradesh and 
